éå»1ã¶æéã«Sarepta Therapeutics Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã27åã«åºã¥ãããŒã¿ã
仿ãSRPTã¯3ä»¶ã®ãè²·ããã12ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã5ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããSRPTã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯22.509ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -0.046ã«ç¶ããSRPTã®FY2026Q3ã®EPSã¯0.140ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -0.05 ã§ããããSarepta Therapeutics IncSRPT ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 3.15 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD 0.14 ãšäºæ³ãããŸãã